🔗 Share this article

This year's prestigious award in medical science was awarded for transformative findings that clarify how the immune system targets dangerous pathogens while protecting the body's own cells.

Three esteemed researchers—Japan's Shimon Sakaguchi and US experts Dr. Brunkow and Fred Ramsdell—share this accolade.

The work uncovered specialized "sentinels" within the defense system that eliminate rogue immune cells capable of harming the organism.

These discoveries are now paving the way for innovative therapies for autoimmune diseases and cancer.

These laureates will divide a prize fund valued at 11m SEK.

Crucial Findings

"The work has been decisive for understanding how the body's defenses functions and the reason we do not all suffer from serious autoimmune diseases," stated the head of the Nobel Committee.

This team's research address a fundamental question: In what way does the immune system defend us from countless invaders while keeping our own tissues intact?

Our body's protection system employs white blood cells that scan for signs of infection, including viruses and bacteria it has not met before.

These defenders utilize detectors—known as receptors—that are produced by chance in a vast number of combinations.

This gives the immune system the ability to fight a broad range of invaders, but the unpredictability of the mechanism inevitably creates white blood cells that can attack the host.

Security Guards of the Body

Researchers previously knew that a portion of these harmful white blood cells were eliminated in the immune organ—where white blood cells mature.

This year's award recognizes the discovery of regulatory T-cells—described as the immune system's "peacekeepers"—which patrol the system to neutralize any immune cells that assault the healthy cells.

We know that this process fails in self-attack conditions such as juvenile diabetes, MS, and rheumatoid arthritis.

A prize committee added, "The findings have established a new field of investigation and accelerated the development of new therapies, for instance for tumors and autoimmune diseases."

Regarding malignancies, T-regs prevent the body from attacking the growth, so studies are focused on lowering their numbers.

In autoimmune diseases, experiments are exploring boosting T-reg cells so the organism is no longer being harmed. A comparable approach could also be useful in reducing the risks of transplanted organ failure.

Innovative Studies

Professor Shimon Sakaguchi, of Osaka University, conducted tests on mice that had their thymus removed, leading to self-attack conditions.

The researcher showed that injecting defense cells from healthy animals could stop the illness—suggesting there was a mechanism for blocking immune cells from harming the host.

Dr. Brunkow, from the a research center in a US city, and Dr. Ramsdell, now at a biotech firm in San Francisco, were studying an genetic autoimmune disease in mice and people that resulted in the identification of a genetic factor critical for how regulatory T-cells operate.

"The groundbreaking research has revealed how the immune system is kept in check by T-reg cells, preventing it from accidentally targeting the healthy cells," said a leading physiology specialist.

"This research is a remarkable illustration of how basic physiological study can have far-reaching consequences for public health."